247 related articles for article (PubMed ID: 25597981)
21. Implantable cardioverter-defibrillator recipient attitudes towards device deactivation: how much do patients want to know?
Raphael CE; Koa-Wing M; Stain N; Wright I; Francis DP; Kanagaratnam P
Pacing Clin Electrophysiol; 2011 Dec; 34(12):1628-33. PubMed ID: 21955046
[TBL] [Abstract][Full Text] [Related]
22. Planning for Deactivation of Implantable Cardioverter Defibrillators at the End of Life in Patients With Heart Failure.
Brady DR
Crit Care Nurse; 2016 Dec; 36(6):24-31. PubMed ID: 27908943
[TBL] [Abstract][Full Text] [Related]
23. Implantable cardioverter defibrillator (ICD) deactivation discussions: Reality versus recommendations.
Hill L; McIlfatrick S; Taylor BJ; Dixon L; Cole BR; Moser DK; Fitzsimons D
Eur J Cardiovasc Nurs; 2016 Feb; 15(1):20-9. PubMed ID: 25903823
[TBL] [Abstract][Full Text] [Related]
24. [ICD in elderly patients].
Israel CW
Herzschrittmacherther Elektrophysiol; 2017 Mar; 28(1):20-28. PubMed ID: 28220241
[TBL] [Abstract][Full Text] [Related]
25. DNR and ECMO: a paradox worth exploring.
Meltzer EC; Ivascu NS; Fins JJ
J Clin Ethics; 2014; 25(1):13-9. PubMed ID: 24779313
[TBL] [Abstract][Full Text] [Related]
26. The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.
Carlsson J; Paul NW; Dann M; Neuzner J; Pfeiffer D
Dtsch Arztebl Int; 2012 Aug; 109(33-34):535-41. PubMed ID: 23152737
[TBL] [Abstract][Full Text] [Related]
27. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life.
Mueller PS; Hook CC; Hayes DL
Mayo Clin Proc; 2003 Aug; 78(8):959-63. PubMed ID: 12911044
[TBL] [Abstract][Full Text] [Related]
28. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.
Kramer DB; Kesselheim AS; Salberg L; Brock DW; Maisel WH
Am J Cardiol; 2011 Apr; 107(7):1071-1075.e5. PubMed ID: 21296323
[TBL] [Abstract][Full Text] [Related]
29. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
Tanawuttiwat T; Garisto JD; Salow A; Glad JM; Szymkiewicz S; Saltzman HE; Kutalek SP; Carrillo RG
Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055
[TBL] [Abstract][Full Text] [Related]
30. Treating or Killing? The Divergent Moral Implications of Cardiac Device Deactivation.
Pilkington BC
J Med Philos; 2020 Jan; 45(1):28-41. PubMed ID: 31889187
[TBL] [Abstract][Full Text] [Related]
31. Defibrillator Deactivation against a Patient's Wishes: Perspectives of Electrophysiology Practitioners.
Daeschler M; Verdino RJ; Caplan AL; Kirkpatrick JN
Pacing Clin Electrophysiol; 2015 Aug; 38(8):917-24. PubMed ID: 25683098
[TBL] [Abstract][Full Text] [Related]
32. Octo- and nonagenarians' outlook on life and death when living with an implantable cardioverter defibrillator: a cross-sectional study.
Thylén I; Moser DK; Strömberg A
BMC Geriatr; 2018 Oct; 18(1):250. PubMed ID: 30342484
[TBL] [Abstract][Full Text] [Related]
33. Deactivation of implantable cardioverter defibrillator in Japanese patients with end-stage heart failure.
Nakazawa M; Suzuki T; Shiga T; Suzuki A; Hagiwara N
J Arrhythm; 2021 Feb; 37(1):196-202. PubMed ID: 33664903
[TBL] [Abstract][Full Text] [Related]
34. Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score.
van Rees JB; Borleffs CJ; van Welsenes GH; van der Velde ET; Bax JJ; van Erven L; Putter H; van der Bom JG; Schalij MJ
Heart; 2012 Jun; 98(11):872-7. PubMed ID: 22581736
[TBL] [Abstract][Full Text] [Related]
35. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
36. ICD recipients' understanding of ethical issues, ICD function, and practical consequences of withdrawing the ICD in the end-of-life.
Strömberg A; Fluur C; Miller J; Chung ML; Moser DK; Thylén I
Pacing Clin Electrophysiol; 2014 Jul; 37(7):834-42. PubMed ID: 24483943
[TBL] [Abstract][Full Text] [Related]
37. Patients' perspective on deactivation of the implantable cardioverter-defibrillator near the end of life.
Pedersen SS; Chaitsing R; Szili-Torok T; Jordaens L; Theuns DA
Am J Cardiol; 2013 May; 111(10):1443-7. PubMed ID: 23490027
[TBL] [Abstract][Full Text] [Related]
38. Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches.
Borne RT; Varosy PD; Masoudi FA
JAMA Intern Med; 2013 May; 173(10):859-65. PubMed ID: 23546173
[TBL] [Abstract][Full Text] [Related]
39. Do not resuscitate orders and the cost of death.
Maksoud A; Jahnigen DW; Skibinski CI
Arch Intern Med; 1993 May; 153(10):1249-53. PubMed ID: 8494477
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain.
van Rees JB; Borleffs CJ; Thijssen J; de Bie MK; van Erven L; Cannegieter SC; Bax JJ; Schalij MJ
Europace; 2012 Jan; 14(1):66-73. PubMed ID: 21920909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
